Chimerix Profit Margin 2011-2018 | CMRX
Current and historical gross margin, operating margin and net profit margin for Chimerix (CMRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chimerix net profit margin as of December 31, 2018 is -951.77%.
|Chimerix Annual Profit Margins
|Chimerix Quarterly Profit Margins
||Medical Products Manufacturing
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.